“Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels”, J. Can. Res. Updates, vol. 5, no. 2, pp.  67–72, Mar. 2016, doi: 10.6000/1929-2279.2016.05.02.4.